v2.4.0.6
Consolidated Statements Of Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Revenues:      
Product sales $ 8,102,359 $ 7,389,921 $ 6,469,311
Royalty revenues 268,827 545,970 491,818
Contract and other revenues 14,199 13,529 50,254
Total revenues 8,385,385 7,949,420 7,011,383
Costs and expenses:      
Cost of goods sold 2,124,410 1,869,876 1,595,558
Research and development 1,229,151 1,072,930 939,918
Selling, general and administrative 1,241,983 1,044,392 946,686
Total costs and expenses 4,595,544 3,987,198 3,482,162
Income from operations 3,789,841 3,962,222 3,529,221
Interest and other income, net 66,581 60,287 42,397
Interest expense (205,418) (108,961) (69,662)
Income before provision for income taxes 3,651,004 3,913,548 3,501,956
Provision for income taxes 861,945 1,023,799 876,364
Net income 2,789,059 2,889,749 2,625,592
Net loss attributable to noncontrolling interest 14,578 11,508 10,163
Net income attributable to Gilead $ 2,803,637 $ 2,901,257 $ 2,635,755
Net income per share attributable to Gilead common stockholders - basic $ 3.62 $ 3.39 $ 2.91
Shares used in per share calculation - basic 774,903 856,060 904,604
Net income per share attributable to Gilead common stockholders - diluted $ 3.55 $ 3.32 $ 2.82
Shares used in per share calculation - diluted 790,118 873,396 934,109